Rock Springs Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001595725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 105 positions · Total reported value $1.85B · Top-10 concentration 43.2% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 39.8% · 9 new · 28 cut · 8 exited

Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Rock Springs Capital Management LP disclosed 105 equity positions with a combined reported value of $1.85B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.2% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were RVMD ($178.42M), TVTX ($129.78M), LLY ($114.20M). By sector, the heaviest allocations are Health Care 96.9%, Industrials 1.3%.

Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 85% of names.

The largest new positions opened in Q3 2026 were ARTV ($10.93M), ABCL ($4.01M), IONS ($2.92M).

Of the 8 positions fully exited versus the prior quarter, the largest were MDT ($2.42M), DNTH ($1.98M), ALT ($1.43M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ARTV ARTIVA BIOTHERAPEUTICS INC · $10.93M
  • ABCL ABCELLERA BIOLOGICS INC · $4.01M
  • IONS IONIS PHARMACEUTICALS INC · $2.92M
  • IMVT IMMUNOVANT INC · $2.37M
  • AVIR ATEA PHARMACEUTICALS INC · $2.26M
  • CELC CELCUITY INC · $2.03M
  • CLYM CLIMB BIO INC · $1.34M
  • HUM HUMANA INC · $1.28M

Fully Exited (vs previous quarter)

  • MDT MEDTRONIC PLC · prev qtr: $2.42M
  • DNTH DIANTHUS THERAPEUTICS INC · prev qtr: $1.98M
  • ALT ALTIMMUNE INC · prev qtr: $1.43M
  • SGRY SURGERY PARTNERS INC · prev qtr: $1.41M
  • ORKA ORUKA THERAPEUTICS INC · prev qtr: $1.15M
  • VKTX VIKING THERAPEUTICS INC · prev qtr: $994.75K
  • GKOS GLAUKOS CORP · prev qtr: $663.86K
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · prev qtr: $208.25K

Insider Transactions (Form 4)

Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q3 2026 it reported 105 US equity positions with a combined value of $1.85B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-78511 (status: Approved), registered 2013-09-27
  • Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 105 positions · $1.85B reported value (Q3 2026)
  • Top 10 holdings = 43.2% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 9.7%
  • Average position size: $17.60M

Sector Tilt

  • Health Care 96.9%
  • Industrials 1.3%
  • Consumer Discretionary 0.9%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 9 new, 30 added, 28 reduced, 8 exited
  • 38 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund reduced exposure to biotech/clinical-stage names (RVMD, MIRM, KYMR, SRRK) while adding to established pharma (LLY, MDGL) and healthcare services (UNH), suggesting a cautious shift toward more stable, cash-generative healthcare assets amid volatility. 2. Key moves: - Reduced: RVMD (shares -21.3%), MIRM (-2.3%), KYMR (-9.6%), SRRK (-4.6%). - Added: TVTX (+1.1%), MDGL (+1.3%), INSM (+0.9%), UNH (+44.7%). 3. Portfolio structure: Active, concentrated (105 positions), with heavy Health Care bias (>90%). Focuses on high-growth biotech but trims speculative names, indicating moderate risk appetite. 4. Per-holding one-liner: - RVMD: Revolution Medicines (unverified), biotech. - TVTX: Traverze Therapeutics (unverified), biotech. - LLY: Eli Lilly, established pharma. - MDGL: Madrigal Pharmaceuticals (unverified), biotech. - MIRM: Mirum Pharmaceuticals (unverified), biotech. - RYTM: Rhythm Pharmaceuticals (unverified), biotech. - KYMR: Kymera Therapeutics (unverified), biotech. - INSM: Insmed, biotech. - UNH: UnitedHealth, healthcare services. - SRRK: Scholar Rock (unverified), biotech. 5. Style summary: Rotating from volatile clinical-stage biotech toward established pharma and healthcare services, trimming losers while adding select names.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:25

Sector Allocation

Health Care 96.9%
Technology 0.4%
Other 0.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 869.26K $178.42M 9.65%
9.65%
Reduce
2 2.20M $129.78M 7.02%
7.02%
Add
3 98.70K $114.20M 6.18%
6.18%
Hold
4 177.25K $89.33M 4.83%
4.83%
Add
5 779.79K $66.66M 3.61%
3.61%
Reduce
6 692.60K $65.95M 3.57%
3.57%
Hold
7 409.63K $45.79M 2.48%
2.48%
Reduce
8 365.25K $41.69M 2.26%
2.26%
Add
9 92.25K $33.86M 1.83%
1.83%
Add
10 682.65K $32.99M 1.78%
1.78%
Reduce
11 144.00K $32.81M 1.77%
1.77%
Reduce
12 125.00K $31.95M 1.73%
1.73%
Hold
13 1.60M $31.25M 1.69%
1.69%
Add
14 273.95K $31.14M 1.69%
1.69%
Add
15 72.25K $29.38M 1.59%
1.59%
Reduce
16 30.00K $28.77M 1.56%
1.56%
Reduce
17 575.00K $28.61M 1.55%
1.55%
Hold
18 293.50K $25.33M 1.37%
1.37%
Reduce
19 535.00K $23.35M 1.26%
1.26%
Add
20 285.12K $22.41M 1.21%
1.21%
Add
21 756.77K $22.02M 1.19%
1.19%
Add
22 653.34K $21.17M 1.15%
1.15%
Reduce
23 262.50K $20.89M 1.13%
1.13%
Hold
24 791.31K $20.84M 1.13%
1.13%
Reduce
25 1.41M $20.60M 1.11%
1.11%
Hold
26 648.33K $20.57M 1.11%
1.11%
Hold
27 640.32K $20.02M 1.08%
1.08%
Hold
28 3.79M $19.94M 1.08%
1.08%
Reduce
29 524.76K $19.52M 1.06%
1.06%
Reduce
30 60.00K $19.10M 1.03%
1.03%
Reduce
31 662.92K $18.89M 1.02%
1.02%
Hold
32 577.28K $18.64M 1.01%
1.01%
Hold
33 130.50K $18.51M 1.00%
1.00%
Reduce
34 393.66K $18.05M 0.98%
0.98%
Reduce
35 575.43K $17.75M 0.96%
0.96%
Hold
36 244.00K $16.92M 0.92%
0.92%
Hold
37 76.30K $16.90M 0.92%
0.92%
Hold
38 275.35K $16.14M 0.87%
0.87%
Reduce
39 847.21K $16.13M 0.87%
0.87%
Add
40 472.33K $15.71M 0.85%
0.85%
Reduce
41 613.94K $14.93M 0.81%
0.81%
Add
42 891.87K $14.37M 0.78%
0.78%
Reduce
43 925.09K $13.90M 0.75%
0.75%
Reduce
44 502.08K $13.54M 0.73%
0.73%
Hold
45 438.50K $13.43M 0.73%
0.73%
Reduce
46 201.84K $13.30M 0.72%
0.72%
Add
47 192.25K $12.65M 0.69%
0.69%
Add
48 389.36K $12.47M 0.68%
0.68%
Reduce
49 484.95K $12.19M 0.66%
0.66%
Hold
50 715.00K $12.09M 0.65%
0.65%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 26% of its Top-10 each quarter and backtests at F1 74% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 74% · recall 74% · F1 74% · avg rank error 2.5 · Top-10 turnover 26%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 60% 60% 60% BPMC · IMCR · KRTX · PEN · EVH · HUM · UNH · CERE · AGL · ISRG BPMC · IMCR · EVH · ISRG · UNH · PEN · IDXX · ACHC · ARGX · BSX
2024-Q2 60% 60% 60% BPMC · IMCR · EVH · ISRG · UNH · PEN · ACHC · IDXX · LLY · ARGX UNH · ISRG · NBIX · LLY · ARGX · ACHC · RARE · EVH · MDGL · BSX
2024-Q3 70% 70% 70% UNH · ISRG · NBIX · LLY · ARGX · ACHC · RARE · EVH · MDGL · ALNY UNH · ISRG · ARGX · LLY · RARE · NBIX · EXAS · BPMC · ALNY · TVTX
2024-Q4 80% 80% 80% UNH · ISRG · LLY · ARGX · RARE · NBIX · BPMC · EXAS · ALNY · TVTX ARGX · ISRG · LLY · NBIX · BPMC · UNH · TVTX · MDGL · RARE · RYTM
2025-Q1 80% 80% 80% ARGX · LLY · ISRG · BPMC · NBIX · TVTX · UNH · MDGL · RARE · RYTM ARGX · LLY · BPMC · MDGL · UNH · TVTX · ISRG · RARE · PEN · RVMD
2025-Q2 60% 60% 60% ARGX · BPMC · LLY · MDGL · TVTX · RARE · UNH · RVMD · ISRG · PEN ARGX · LLY · MRUS · RYTM · INSM · RARE · RVMD · ISRG · MDGL · MIRM
2025-Q3 80% 80% 80% ARGX · LLY · MRUS · INSM · RYTM · RVMD · RARE · ISRG · MDGL · MIRM ARGX · LLY · RYTM · MDGL · RVMD · MRUS · MIRM · INSM · TVTX · ASND
2025-Q4 80% 80% 80% ARGX · LLY · RYTM · RVMD · MDGL · INSM · MIRM · MRUS · TVTX · AGIO LLY · RVMD · ARGX · TVTX · MDGL · RYTM · EXAS · MIRM · INSM · GPCR
2026-Q1 80% 80% 80% LLY · RVMD · TVTX · ARGX · MDGL · RYTM · EXAS · MIRM · INSM · GPCR RVMD · LLY · MDGL · MIRM · ARGX · RYTM · INSM · ASND · XENE · TVTX
2026-Q2 90% 90% 90% RVMD · MDGL · LLY · MIRM · ARGX · RYTM · INSM · ASND · XENE · TVTX RVMD · TVTX · LLY · MDGL · MIRM · RYTM · KYMR · ARGX · ASND · XENE
2026-Q3 ★ 70% 70% 70% RVMD · TVTX · LLY · MDGL · MIRM · RYTM · KYMR · ARGX · ASND · XENE RVMD · TVTX · LLY · MDGL · MIRM · RYTM · KYMR · INSM · UNH · SRRK

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings25 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return-4.66%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+12.36%vs benchmark
Barra annualised vol27.8%Model estimate
Realised vol29.6%Annualised in window
Weighted beta0.70Raw exposure
Factor / specific risk52% / 48%Share of variance
Top-10 concentration83.3%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2311-16Rock Springs Capital Management LPQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-4.66%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+12.36%Portfolio − benchmark
Arithmetic return sum-4.21%Difference vs compounded is the cross term
Weighted raw beta0.70Weighted holding betas
Realised volatility (annualised)29.64%Daily returns in window
Barra model volatility (annualised)27.79%Factor + specific
Factor share of variance52.2%Barra factors
Specific share of variance47.8%Stock residuals
Reported value$717.2M13F long US equity

2. Return attribution

The -4.21% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +1.03% 24.6%
Momentum & Growth 3 -5.03% -119.5%
Volatility & Tail Risk 7 +4.82% 114.7%
Industry 12 +6.78% 161.2%
Specific 1 -11.82% -280.9%
Return attribution (style + industry, %)-7.3-3.6+0.0+3.6+7.3Amihud Illiquidity-0.34Short-term Reversal+0.43Non-linear Size+0.52Skewness-0.65Beta-0.77Size+0.77Growth-0.90Mid Cap-1.02Turnover+1.17Historical Volatility-1.47Kurtosis+2.44Momentum-4.56Residual Volatility+5.18Health Care+6.73
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.96 +6.98% +6.73% 160.1%
Residual Volatility Style +1.57 +3.29% +5.18% 123.1%
Kurtosis Style +0.32 +7.51% +2.44% 58.0%
Turnover Style -0.24 -4.80% +1.17% 27.9%
Size Style -0.40 -1.95% +0.77% 18.3%
Non-linear Size Style +0.51 +1.01% +0.52% 12.3%
Short-term Reversal Style +0.49 +0.87% +0.43% 10.2%
Max Drawdown Style -0.19 -1.76% +0.33% 7.9%
Liquidity Style -0.21 +0.36% -0.07% -1.8%
Leverage (Downside Vol) Style +0.14 -1.71% -0.24% -5.7%
Amihud Illiquidity Style +0.75 -0.45% -0.34% -8.0%
Skewness Style +0.15 -4.39% -0.65% -15.6%
Beta Style -0.17 +4.44% -0.77% -18.2%
Growth Style -0.51 +1.75% -0.90% -21.3%
Mid Cap Style +0.53 -1.94% -1.02% -24.2%
Historical Volatility Style +0.10 -14.00% -1.47% -34.9%
Momentum Style +1.14 -4.00% -4.56% -108.4%
Specific Specific — — -11.82% -280.9%

3. Risk attribution

Annualised volatility is 27.79%; factor risk explains 52.2% of variance and specific risk 47.8%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-51.6-25.8+0.0+25.8+51.6Beta-1.03Non-linear Size-0.52Growth-0.36Industrials+0.49Kurtosis+0.58Max Drawdown+0.72Amihud Illiquidity+1.06Mid Cap+1.12Short-term Reversal+1.21Size+1.79Residual Volatility+3.58Momentum+12.28Health Care+31.00Specific+47.78
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 47.8% +13.28% 13.3%
Health Care Industry +0.96 31.0% +8.62% 8.6%
Momentum Style +1.14 12.3% +3.41% 3.4%
Residual Volatility Style +1.57 3.6% +1.00% 1.0%
Size Style -0.40 1.8% +0.50% 0.5%
Short-term Reversal Style +0.49 1.2% +0.34% 0.3%
Mid Cap Style +0.53 1.1% +0.31% 0.3%
Amihud Illiquidity Style +0.75 1.1% +0.29% 0.3%
Max Drawdown Style -0.19 0.7% +0.20% 0.2%
Kurtosis Style +0.32 0.6% +0.16% 0.2%
Industrials Industry +0.03 0.5% +0.14% 0.1%
Growth Style -0.51 -0.4% -0.10% -0.1%
Non-linear Size Style +0.51 -0.5% -0.14% -0.1%
Beta Style -0.17 -1.0% -0.29% -0.3%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-0.9-0.10.71.62.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.40 +2.10 -2.50
Non-linear Size +0.51 +1.68 -1.17
Mid Cap +0.53 +0.13 +0.40
Beta -0.17 +1.29 -1.47
Momentum +1.14 +0.72 +0.42
Short-term Reversal +0.49 -0.64 +1.13
Residual Volatility +1.57 -0.40 +1.97
Historical Volatility +0.10 +0.86 -0.76
Liquidity -0.21 +0.11 -0.32
Amihud Illiquidity +0.75 +1.16 -0.40
Turnover -0.24 +0.21 -0.45
Growth -0.51 +0.58 -1.10
Leverage (Downside Vol) +0.14 +0.14 -0.00
Skewness +0.15 +0.24 -0.09
Kurtosis +0.33 +0.21 +0.11
Max Drawdown -0.19 -0.08 -0.11

5. Industry allocation & Brinson

Industry allocation (weight, %)-9.619.348.277.1106.0Information TechnologyCommunication ServicesUtilitiesConsumer DiscretionaryConsumer StaplesIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.3% 0.8% +3.38% +15.26% -0.17% -0.10% +0.06% -0.12%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 3.3% 11.1% +3.38% +4.36% -1.68% -0.11% +0.08% -0.37%
Health Care 96.4% 1.7% -4.45% +8.29% +24.06% -0.22% -12.06% -4.43%
Total +23.87% +16.03% -28.37% +11.53%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
RVMD REVOLUTION MEDICINES INC Health Care 24.88% -18.70% -4.65% Reduce
LLY ELI LILLY & CO Health Care 15.92% +23.73% +3.78% Hold
MDGL MADRIGAL PHARMACEUTICALS INC Health Care 12.46% -15.87% -1.98% Add
INSM INSMED INC Health Care 5.81% +7.66% +0.45% Add
UNH UNITEDHEALTH GROUP INC Health Care 4.72% +12.24% +0.58% Add
SRRK SCHOLAR ROCK HLDG CORP Health Care 4.60% -7.82% -0.36% Reduce
ISRG INTUITIVE SURGICAL INC Health Care 4.10% +7.65% +0.31% Reduce
ARGX ARGENX SE Health Care 4.01% -0.83% -0.03% Reduce
DXCM DEXCOM INC Health Care 3.53% -5.42% -0.19% Reduce
BSX BOSTON SCIENTIFIC CORP Health Care 3.26% +0.09% +0.00% Add
GPCR STRUCTURE THERAPEUTICS INC Health Care 2.79% -40.61% -1.13% Hold
DHR DANAHER CORP DEL Industrials 2.36% +3.77% +0.09% Hold
NAMS NEWAMSTERDAM PHARMA COMPANY Health Care 2.08% -19.98% -0.42% Add
BBIO BRIDGEBIO PHARMA INC Health Care 1.76% +17.57% +0.31% Add
TNGX TANGO THERAPEUTICS INC Health Care 1.60% -3.13% -0.05% Add
ALNY ALNYLAM PHARMACEUTICALS INC Health Care 1.31% -35.26% -0.46% Reduce
CORT CORCEPT THERAPEUTICS INC Health Care 1.16% -39.93% -0.46% Hold
TMO THERMO FISHER SCIENTIFIC INC Industrials 0.94% +2.41% +0.02% Hold
NGNE NEUROGENE INC Health Care 0.60% -16.25% -0.10% Add
NVO NOVO-NORDISK A S Health Care 0.59% +9.73% +0.06% Add
Contribution rank Symbol Sector Weight Return Contribution
1 LLY Health Care 15.92% +23.73% +3.78%
2 UNH Health Care 4.72% +12.24% +0.58%
3 INSM Health Care 5.81% +7.66% +0.45%
4 ISRG Health Care 4.10% +7.65% +0.31%
5 BBIO Health Care 1.76% +17.57% +0.31%
6 DHR Industrials 2.36% +3.77% +0.09%
7 NVO Health Care 0.59% +9.73% +0.06%
8 HUM Health Care 0.18% +20.88% +0.04%
9 ALNY Health Care 1.31% -35.26% -0.46%
10 CORT Health Care 1.16% -39.93% -0.46%
11 GPCR Health Care 2.79% -40.61% -1.13%
12 MDGL Health Care 12.46% -15.87% -1.98%
13 RVMD Health Care 24.88% -18.70% -4.65%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -4.66%, versus -17.01% for the QQQ synthetic benchmark — an excess of +12.36%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +6.73%, Residual Volatility +5.18%, Kurtosis +2.44%; the largest drags came from Momentum -4.56%, Historical Volatility -1.47%, Mid Cap -1.02%. Specific (stock-level) return contributed -11.82%.
  3. Risk attribution: Barra model volatility is 27.79% annualised; factor risk explains 52% of variance and specific risk 48%. The largest factor risk sources are Health Care 31.0%, Momentum 12.3%, Residual Volatility 3.6%.
  4. Style tilt: size -0.40, momentum +1.14, volatility +0.10, liquidity -0.21; the weighted raw beta is 0.70. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+94.7 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +23.87%, selection +16.03% and interaction -28.37%.
  6. Concentration: the top-10 positions are 83.3% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Rock Springs Capital Management LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Rock Springs Capital Management LP reported 105 equity positions worth $1.85B in aggregate; its largest disclosed positions were RVMD ($178.42M), TVTX ($129.78M), LLY ($114.20M).

How large is Rock Springs Capital Management LP's portfolio?

Rock Springs Capital Management LP reported $1.85B of long equity holdings across 105 positions as of 2026-Q3. Top-10 holdings account for 43.2% of reported value.

What is Rock Springs Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rock-springs-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →